Status:

COMPLETED

Role of Positron Emission Tomography/ Computed Tomography (PET/CT) and in Bone Metastases.

Lead Sponsor:

Assiut University

Conditions:

Bone Metastases

Eligibility:

All Genders

Brief Summary

The aim of this study is to detect bone metastases by PET/CT examination in cancer patients.

Detailed Description

Bone is a fertile soil for dissemination of metastatic tumor cells which can cause either osteolytic ( destructive) or osteoblastic (sclerotic) or mixed lesions in advanced cancer. Bone metastases are...

Eligibility Criteria

Inclusion

  • patients diagnosed with different types of malignant tumor, suspected or diagnosed to have bone metastases and will do PET/CT examination
  • patients diagnosed with different types of malignant tumor, with accidently discovered bone metastases during PET/CT examination.
  • patients conscious to provide informed consent.

Exclusion

  • pregnant women.
  • patients with blood sugar \> 200 mg/dL.
  • patients unable to sleep in a fixed position for 20 minutes.
  • severely ill patients who aren't capable of complying with study procedures or comatose patients.

Key Trial Info

Start Date :

November 1 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2021

Estimated Enrollment :

66 Patients enrolled

Trial Details

Trial ID

NCT04080271

Start Date

November 1 2019

End Date

December 1 2021

Last Update

June 30 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Assiut university hospital

Asyut, Egypt

Role of Positron Emission Tomography/ Computed Tomography (PET/CT) and in Bone Metastases. | DecenTrialz